• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BioGaia

124.10 SEK

+1.47 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.47 %
-3.65 %
+12.51 %
+16.85 %
+26.31 %
+20.14 %
+12.72 %
+40.70 %
+1,647.07 %

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
12.55B SEK
Turnover
20.15M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
37.72
Dividend yield-%
3.22 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
17.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/7/2026, 4:00 PM

Bulletin from Annual General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q1'26
Webcast5/7/2026, 7:30 AM

BioGaia, Audiocast, Q1'26

BioGaia
Regulatory press release5/7/2026, 6:00 AM

BioGaia AB: Interim Management Statement January - March 2026

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/30/2026, 1:00 PM

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release3/30/2026, 9:00 AM

BioGaia Annual and Sustainability Report 2025 published

BioGaia
Press release3/17/2026, 12:00 PM

BioGaia exercises option to acquire remaining shares in Nutraceutics

BioGaia
BioGaia, Audiocast, Q4'25
Webcast2/12/2026, 8:30 AM

BioGaia, Audiocast, Q4'25

BioGaia
Regulatory press release2/12/2026, 7:00 AM

BioGaia AB: Year-end report January - December 2025

BioGaia
Regulatory press release2/3/2026, 7:00 AM

BioGaia's results for the fourth quarter to exceed market expectations

BioGaia
BioGaia, Audiocast, Q3'25
Webcast10/22/2025, 7:30 AM

BioGaia, Audiocast, Q3'25

BioGaia
Regulatory press release10/22/2025, 6:00 AM

BioGaia AB: Interim Management Statement January - September 2025

BioGaia
Regulatory press release8/22/2025, 3:30 PM

Extraordinary General Meeting of BioGaia

BioGaia
Regulatory press release7/25/2025, 7:30 AM

Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)

BioGaia
BioGaia, Audiocast, Q2'25
Webcast7/18/2025, 7:30 AM

BioGaia, Audiocast, Q2'25

BioGaia
Regulatory press release7/18/2025, 6:00 AM

BioGaia AB: Interim Report January - June 2025

BioGaia
Press release7/16/2025, 8:00 AM

BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation

BioGaia
Regulatory press release5/30/2025, 9:00 AM

Change in the number of votes in BioGaia AB (publ)

BioGaia
Regulatory press release5/7/2025, 4:30 PM

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast, Q1'25
Webcast5/7/2025, 7:30 AM

BioGaia, Audiocast, Q1'25

BioGaia
Regulatory press release5/7/2025, 6:00 AM

BioGaia AB: Interim Management Statement January - March 2025

BioGaia